全文获取类型
收费全文 | 55086篇 |
免费 | 4471篇 |
国内免费 | 487篇 |
专业分类
耳鼻咽喉 | 671篇 |
儿科学 | 1600篇 |
妇产科学 | 1068篇 |
基础医学 | 7914篇 |
口腔科学 | 959篇 |
临床医学 | 5151篇 |
内科学 | 12262篇 |
皮肤病学 | 998篇 |
神经病学 | 4568篇 |
特种医学 | 1926篇 |
外国民族医学 | 16篇 |
外科学 | 7553篇 |
综合类 | 1572篇 |
现状与发展 | 1篇 |
一般理论 | 18篇 |
预防医学 | 4213篇 |
眼科学 | 1257篇 |
药学 | 3711篇 |
6篇 | |
中国医学 | 653篇 |
肿瘤学 | 3927篇 |
出版年
2023年 | 400篇 |
2022年 | 878篇 |
2021年 | 1841篇 |
2020年 | 1069篇 |
2019年 | 1444篇 |
2018年 | 1766篇 |
2017年 | 1229篇 |
2016年 | 1224篇 |
2015年 | 1506篇 |
2014年 | 1931篇 |
2013年 | 2536篇 |
2012年 | 3672篇 |
2011年 | 3698篇 |
2010年 | 2176篇 |
2009年 | 1816篇 |
2008年 | 2855篇 |
2007年 | 2885篇 |
2006年 | 2799篇 |
2005年 | 2639篇 |
2004年 | 2385篇 |
2003年 | 2197篇 |
2002年 | 2113篇 |
2001年 | 1262篇 |
2000年 | 1237篇 |
1999年 | 1140篇 |
1998年 | 523篇 |
1997年 | 464篇 |
1996年 | 398篇 |
1995年 | 336篇 |
1994年 | 324篇 |
1993年 | 287篇 |
1992年 | 622篇 |
1991年 | 601篇 |
1990年 | 583篇 |
1989年 | 522篇 |
1988年 | 558篇 |
1987年 | 493篇 |
1986年 | 448篇 |
1985年 | 469篇 |
1984年 | 360篇 |
1983年 | 287篇 |
1982年 | 254篇 |
1981年 | 228篇 |
1980年 | 252篇 |
1979年 | 287篇 |
1978年 | 198篇 |
1977年 | 203篇 |
1976年 | 197篇 |
1974年 | 201篇 |
1972年 | 184篇 |
排序方式: 共有10000条查询结果,搜索用时 437 毫秒
51.
52.
53.
54.
Isaac Samuel M.D. Mark A. Yorek Ph.D. Asgar Zaheer Ph.D. Rory A. Fisher Ph.D. 《Journal of gastrointestinal surgery》2006,10(7):950-959
Using a unique surgical model (the donor rat model), we showed previously that duodenal replacement of bile-pancreatic juice,
obtained fresh from a donor rat, ameliorates ligation-induced acute pancreatitis. We hypothesize that bile-pancreatic juice
exclusion from gut exacerbates Akt/nuclear factor-kB (NF-kB) pathway activation and induces chemokine production in ligation-induced acute pancreatitis. We compared rats with bile-pancreatic
duct ligation to those with duodenal bile-pancreatic juice replacement fresh from a donor rat beginning immediately before
duct ligation. Sham control rats had ducts dissected but not ligated. Rats were killed 1 or 3 hours after operation (n=7/group).
Akt activation (immunoblotting, immune-complex kinase assay, and ELISA), inhibitory protein I-kB (I-kB) activation (immunoblotting), and production of chemokines MCP-1 and RANTES (ELISA) were measured in pancreatic homogenates.
NF-kB was quantitated in nuclear fractions using electrophoretic mobility shift assay. Duct ligation produced significant increases
in pancreatic Akt, IkB, and NF-kB activation and production of MCP-1 and RANTES. Activation of the Akt/NF-kB pathway and increased MCP-1 and RANTES production in response to duct ligation were significantly reduced by bile-pancreatic
juice replacement (ANOVA, P<0.05). Bile-pancreatic juice exclusion stimulates Akt/NF-kB pathway activation and increases chemokine production in ligation-induced acute pancreatitis.
Presented at the annual meeting of The Society for Surgery of the Alimentary Tract, Chicago, Illinois, May 16, 2005 (poster). 相似文献
55.
56.
57.
58.
59.
Y. Le Meur M. Büchler A. Thierry S. Caillard F. Villemain S. Lavaud I. Etienne P.-F. Westeel B. H. de Ligny L. Rostaing E. Thervet J. C. Szelag J.-P. Rérolle A. Rousseau G. Touchard P. Marquet 《American journal of transplantation》2007,7(11):2496-2503
Efficacy and safety of mycophenolate mofetil (MMF) may be optimized with individualized doses based on therapeutic monitoring of its active metabolite, mycophenolic acid (MPA). In this 12-month study, 137 renal allograft recipients from 11 French centers receiving basiliximab, cyclosporine A, MMF and corticosteroids were randomized to receive either concentration-controlled doses or fixed-dose MMF. A novel Bayesian estimator of MPA AUC based on three-point sampling was used to individualize doses on posttransplant days 7 and 14 and months 1, 3 and 6. The primary endpoint was treatment failure (death, graft loss, acute rejection and MMF discontinuation). Data from 65 patients/group were analyzed. At month 12, the concentration-controlled group had fewer treatment failures (p = 0.03) and acute rejection episodes (p = 0.01) with no differences in adverse event frequency. The MMF dose was higher in the concentration-controlled group at day 14 (p < 0.0001), month 1 (p < 0.0001) and month 3 (p < 0.01), as were median AUCs on day 14 (33.7 vs. 27.1 mg*h/L; p = 0.0001) and at month 1 (45.0 vs. 30.9 mg*h/L; p < 0.0001). Therapeutic MPA monitoring using a limited sampling strategy can reduce the risk of treatment failure and acute rejection in renal allograft recipients 12 months posttransplant with no increase in adverse events. 相似文献
60.
Surgery alone has long been the standard treatment for patients with operable non-small-cell lung cancer (NSCLC). However, despite complete resection, 5-year survival rates have been disappointing, with about 50% of patients eventually suffering relapse and death from disease. Randomized trials conducted in the 1980s hinted at a survival benefit for postoperative cisplatin-based regimens, but they were underpowered. A meta-analysis published in 1995 found a nonsignificant 13% reduction in the risk of death associated with cisplatin-based chemotherapy, with an increase of survival of 5% at 5 years. This led to renewed interest in adjuvant chemotherapy in resected NSCLC. Thousands of patients have been included in a new generation of randomized trials in the last 10 years. Most of these recent studies have now been reported and several have demonstrated a clear survival advantage for patients treated with platin-based adjuvant therapy. These results also suggest a greater benefit with modern two-drug regimens. In view of the most recent data, postoperative platin-based chemotherapy can now be considered the standard of care for completely resected NSCLC patients with good performance status. 相似文献